We are live on ! Find out more
ANAB icon

AnaptysBio

136 hedge funds and large institutions have $963M invested in AnaptysBio in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 42 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

29% more capital invested

Capital invested by funds: $749M → $963M (+$215M)

7% more funds holding

Funds holding: 127136 (+9)

0.22% more ownership

Funds ownership: 100.67%100.88% (+0.22%)

10% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 42

Holders
136
Holders Change
+9
Holders Change %
+7.09%
% of All Funds
2.09%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
24
Increased
38
Reduced
42
Closed
15
Calls
$1.51M
Puts
Net Calls
+$1.51M
Net Calls Change
+$1.14M
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Natixis
France
$5.53M +$5.04M +159,000 New
Charles Schwab
27
Charles Schwab
California
$4.74M +$21.4K +674 +0.5%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$4.36M -$1.41M -44,400 -26%
Los Angeles Capital Management
29
Los Angeles Capital Management
California
$4.24M -$275K -8,664 -7%
CAM
30
Cormorant Asset Management
Massachusetts
$3.48M -$9.04M -285,081 -74%
Macquarie Group
31
Macquarie Group
Australia
$3.27M
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$3.1M +$28.2K +889 +1%
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.06M +$5.93K +187 +0.2%
Two Sigma Investments
34
Two Sigma Investments
New York
$3.01M -$1.85M -58,461 -40%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.97M +$112K +3,544 +4%
Massachusetts Financial Services
36
Massachusetts Financial Services
Massachusetts
$2.82M -$475K -14,991 -16%
Walleye Capital
37
Walleye Capital
New York
$2.7M +$2.47M +77,784 New
Morgan Stanley
38
Morgan Stanley
New York
$2.53M +$24.8K +781 +1%
Arrowstreet Capital
39
Arrowstreet Capital
Massachusetts
$2.52M +$2.3M +72,501 New
JAM
40
Jupiter Asset Management
United Kingdom
$2.08M
Fisher Asset Management
41
Fisher Asset Management
Washington
$2.06M +$425K +13,402 +29%
EGI
42
EAM Global Investors
California
$2.04M +$1.86M +58,683 New
PPA
43
Parametric Portfolio Associates
Washington
$1.9M -$80K -2,522 -4%
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$1.56M +$44.1K +1,390 +3%
Rafferty Asset Management
45
Rafferty Asset Management
New York
$1.51M +$418K +13,195 +44%
Ameriprise
46
Ameriprise
Minnesota
$1.48M +$1.35M +42,475 New
EI
47
EAM Investors
California
$1.4M +$1.28M +40,392 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$1.39M +$74.3K +2,342 +6%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.36M
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.35M +$401K +12,657 +48%

ANAB Hedge Fund Activity: Q4 2021 in Review

136 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2021, worth a combined $963M — up 29% from $749M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANAB positions and 15 closed out — a net gain of 9 holders — while 38 added to existing stakes and 42 trimmed.

The largest buyer was Federated Hermes, adding an estimated $21M. The largest seller was Woodline Partners, cutting an estimated $12.8M.

  • 136 institutional investors held AnaptysBio (ANAB) as of Q4 2021, up from 127 in Q3 2021.
  • Funds reported $963M of AnaptysBio stock for Q4 2021, up 29% quarter-over-quarter.
  • 24 funds opened new AnaptysBio positions in Q4 2021 and 15 closed out, a net change of +9 holders.
  • The largest AnaptysBio buyer in Q4 2021 was Federated Hermes, an estimated $21M added.
  • The largest AnaptysBio seller in Q4 2021 was Woodline Partners, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2021.